Linked Life Data

7583571

Source:http://linkedlifedata.com/resource/pubmed/id/7583571

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7583571rdf:typepubmed:Citationlld:pubmed
pubmed-article:7583571lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:7583571lifeskim:mentionsumls-concept:C0003483lld:lifeskim
pubmed-article:7583571lifeskim:mentionsumls-concept:C0205107lld:lifeskim
pubmed-article:7583571lifeskim:mentionsumls-concept:C0085833lld:lifeskim
pubmed-article:7583571lifeskim:mentionsumls-concept:C0221198lld:lifeskim
pubmed-article:7583571lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:7583571lifeskim:mentionsumls-concept:C0205345lld:lifeskim
pubmed-article:7583571lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:7583571pubmed:issue11lld:pubmed
pubmed-article:7583571pubmed:dateCreated1995-12-18lld:pubmed
pubmed-article:7583571pubmed:abstractTextTransgenic mice expressing transgenes for both human apolipoprotein B-100 (h-apoB) and apolipoprotein(a) [apo(a)] were fed a high-fat, atherogenic diet for 14 weeks to examine the effect of lipoprotein(a) [Lp(a)]on the development of aortic fatty lesions. The extent of lesions in the proximal region of the aorta of Lp(a) mice was measured by use of a computer-assisted image analysis of 20 sections per animal and compared with that of nontransgenic mice as well as mice expressing either the apo(a) or h-apoB transgene. The control (n = 23) and apo(a) (n = 22) transgenic mice had very small mean lesions areas (607 versus 128 microns2 per section). The h-apoB-expressing mice (n = 20) had significantly higher mean lesion areas (3288 microns2 per section) than either the control or apo(a) transgenic animals. Coexpression of apo(a) and h-apoB transgenes resulted in only a modest increase in lesion area (4678 microns2 per section, n = 19). Thus, the expression of human apo(a) in C57BL/6/SJL hybrid mice fed an atherogenic diet failed to significantly potentiate the development of aortic fatty lesions in the absence or presence of high levels of h-apoB.lld:pubmed
pubmed-article:7583571pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7583571pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7583571pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7583571pubmed:languageenglld:pubmed
pubmed-article:7583571pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7583571pubmed:citationSubsetIMlld:pubmed
pubmed-article:7583571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7583571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7583571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7583571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7583571pubmed:statusMEDLINElld:pubmed
pubmed-article:7583571pubmed:monthNovlld:pubmed
pubmed-article:7583571pubmed:issn1079-5642lld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:MarcovinaSSlld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:YoungS GSGlld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:MurataJJlld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:HammerR ERElld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:HouckW SWSlld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:MooserVVlld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:SananD ADAlld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:ManciniF PFPlld:pubmed
pubmed-article:7583571pubmed:authorpubmed-author:NewlandD LDLlld:pubmed
pubmed-article:7583571pubmed:issnTypePrintlld:pubmed
pubmed-article:7583571pubmed:volume15lld:pubmed
pubmed-article:7583571pubmed:ownerNLMlld:pubmed
pubmed-article:7583571pubmed:authorsCompleteYlld:pubmed
pubmed-article:7583571pubmed:pagination1911-6lld:pubmed
pubmed-article:7583571pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:meshHeadingpubmed-meshheading:7583571-...lld:pubmed
pubmed-article:7583571pubmed:year1995lld:pubmed
pubmed-article:7583571pubmed:articleTitleRelative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice.lld:pubmed
pubmed-article:7583571pubmed:affiliationDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9046, USA.lld:pubmed
pubmed-article:7583571pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7583571pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7583571pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7583571lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7583571lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7583571lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7583571lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7583571lld:pubmed